Condition
Neuromyelitis Optica Spectrum Disorder Attack clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Neuromyelitis Optica Spectrum Disorder Attack clinical trials that are recruiting, at sites in 2 countries (most in Japan (1), China (1)). By phase: Phase 1/2 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Sivelestat added to standard steroid therapy during an NMOSD attack
This trial tests whether giving sivelestat in addition to standard steroid treatment is safe and helps people with an acute NMOSD attack.
-
Acute treatments for AQP4-positive NMOSD attacks
This project will test whether adding eculizumab or IVIG to high-dose IV steroid pulses helps adults with AQP4-positive NMOSD during an acute attack.
Related topics
Quick answers
How many Neuromyelitis Optica Spectrum Disorder Attack clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in Japan (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.